Skandinaviska Enskilda Banken Ab (Publ) Windtree Therapeutics Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 10, 2021	BUY	$1.66 - $2.27 $24,900 - $34,050	15,000 Added 15.71%	110,500 $228,000
Q2 2021 Aug 10, 2021	BUY	$1.68 - $2.79 $160,440 - $266,445	95,500 New	95,500 $219,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $9.8M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.